XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue from Contracts with Customers (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 01, 2022
Jun. 30, 2023
Jun. 16, 2022
Jun. 30, 2023
Jun. 16, 2022
Dec. 30, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]              
Revenue Reserves $ 263.4 $ 264.5 $ 276.9 $ 264.5 $ 276.9 $ 294.0 $ 272.8
Revenue Reserve Provision 70.5     752.8 715.7    
Revenue Reserve Payments or Credits (84.0)     (782.3) (711.6)    
Net sales $ 85.0 475.0 $ 383.7 899.6 $ 874.6    
Accrued Medicaid   91.3   91.3   89.3  
Accrued rebates   $ 36.4   $ 36.4   55.3  
Transferred at Point in Time [Member]              
Disaggregation of Revenue [Line Items]              
Revenue 83.80% 83.60% 82.40% 82.00% 80.80%    
Transferred over Time [Member]              
Disaggregation of Revenue [Line Items]              
Revenue 16.20% 16.40% 17.60% 18.00% 19.20%    
Royalty [Member]              
Disaggregation of Revenue [Line Items]              
Net sales $ 3.0 $ 0.4 $ 14.9 $ 3.8 $ 34.9    
Rebates and Chargebacks [Member]              
Disaggregation of Revenue [Line Items]              
Revenue Reserves [1] 237.7 243.0 250.6 243.0 250.6 265.3 241.8
Revenue Reserve Provision [1] 68.5     726.0 693.4    
Revenue Reserve Payments or Credits [1] (81.4)     (748.3) (684.6)    
Allowance for Sales Returns [Member]              
Disaggregation of Revenue [Line Items]              
Revenue Reserves 18.4 13.2 18.6 13.2 18.6 16.0 21.5
Revenue Reserve Provision 0.5     5.8 5.2    
Revenue Reserve Payments or Credits (0.7)     (8.6) (8.1)    
Other Sales Deductions [Member]              
Disaggregation of Revenue [Line Items]              
Revenue Reserves 7.3 $ 8.3 $ 7.7 8.3 7.7 $ 12.7 $ 9.5
Revenue Reserve Provision 1.5     21.0 17.1    
Revenue Reserve Payments or Credits $ (1.9)     $ (25.4) $ (18.9)    
[1] Includes $91.3 million and $89.3 million of accrued Medicaid and $36.4 million and $55.3 million of accrued rebates as of June 30, 2023 (Successor) and December 30, 2022 (Successor), respectively, included within accrued and other current liabilities in the unaudited condensed consolidated balance sheets.